Cargando…
Number of risk genotypes is a risk factor for major depressive disorder: a case control study
BACKGROUND: The objective of the study was to determine the genetic basis of Major Depressive Disorder, and the capacity to respond to antidepressant treatment. An association study of 21 candidate polymorphisms relevant to monoamine function and the mechanism of antidepressant response was conducte...
Autores principales: | Garriock, Holly A, Delgado, Pedro, Kling, Mitchel A, Carpenter, Linda L, Burke, Michael, Burke, William J, Schwartz, Thomas, Marangell, Lauren B, Husain, Mustafa, Erickson, Robert P, Moreno, Francisco A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526442/ https://www.ncbi.nlm.nih.gov/pubmed/16822313 http://dx.doi.org/10.1186/1744-9081-2-24 |
Ejemplares similares
-
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada, Eiji, et al.
Publicado: (2016) -
Current issues: women and bipolar disorder
por: Marangell, Lauren B.
Publicado: (2008) -
Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities
por: McLaren, Kimberly D, et al.
Publicado: (2004) -
Informing 21st-Century Risk Assessments with 21st-Century Science
por: Birnbaum, Linda S., et al.
Publicado: (2016) -
Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine
por: Fu, Cynthia HY, et al.
Publicado: (2015)